WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1993021304) METHOD FOR THE INHIBITION OF THE PROLIFERATION OF CANCER CELLS IN A TUMOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1993/021304    International Application No.:    PCT/US1992/003148
Publication Date: 28.10.1993 International Filing Date: 14.04.1992
Chapter 2 Demand Filed:    14.10.1993    
IPC:
A61K 31/28 (2006.01), A61K 38/00 (2006.01), C07K 5/02 (2006.01)
Applicants: THE OHIO STATE UNIVERSITY [US/US]; 200 Administration Building, 190 North Oval Mall, Columbus, OH 43210 (US) (For All Designated States Except US).
KRALICK, Francis, A. [US/US]; (US) (For US Only).
PARRISH, Wayne, B. [US/US]; (US) (For US Only).
WILLETT, Darryl, N. [US/US]; (US) (For US Only)
Inventors: KRALICK, Francis, A.; (US).
PARRISH, Wayne, B.; (US).
WILLETT, Darryl, N.; (US)
Agent: MILLARD, Sidney, W.; Kremblas, Foster & Millard, 7632 Slate Ridge Boulevard, Columbus, OH 43068 (US)
Priority Data:
Title (EN) METHOD FOR THE INHIBITION OF THE PROLIFERATION OF CANCER CELLS IN A TUMOR
(FR) PROCEDE D'INHIBITION DE LA PROLIFERATION DE CELLULES CANCEREUSES DANS UNE TUMEUR
Abstract: front page image
(EN)The invention discloses a biphasic method of treating cancer tumors sensitive to treatment with selenodithiols, which method comprises administering a specific amount of a selenodithiol to the cancer tumor whereby the cancer tumor cells die and the surrounding non-cancerous tissue exhibits cell proliferation in cells sensitive to selenodithiols. A range of ratios of selenodithiol concentration to tumor diameters or volume is claimed.
(FR)L'invention se rapporte à un procédé biphasique du traitement des tumeurs cancéreuses sensibles au traitement aux sélénodithiols. Ce procédé consiste à administrer une quantité spécifique d'un sélénodithiol à une tumeur cancéreuse. Les cellules de la tumeur cancéreuse meurent et le tissu environnant non cancéreux indique la prolifération des cellules dans les cellules sensibles aux sélénodithiols. L'invention divulgue également une plage de taux de concentration de sélénodithiol par rapport au diamètre ou au volume de la tumeur.
Designated States: AU, CA, JP, KR, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, MC, NL, SE).
Publication Language: English (EN)
Filing Language: English (EN)